Evidence map›Paper›PMID 37599657›Full record

ArticleHealth science reports2023

Real-time impact of COVID-19 pandemic on cutaneous leishmaniasis case finding and strategic planning, preventive interventions, control and epidemiology in a region with a high burden of cutaneous leishmaniasis and COVID-19: A cross-sectional descriptive study based on registry data in Ilam-Iran.

Morteza Shams, Ayoub Rashidi, Jasem Mohamadi, Mohamad Moradi, Reza Pakzad, Razi Naserifar, Jahangir Abdi, Fariba Ghelichi, Arezoo Bozorgomid, Nahid Maspi and 4 more

Open access · goldAbstract read
In one paragraph

Article in Health science reports, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 1 pooled it
2.3field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 1 synthesis or guideline pooled it, 8 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 5 institutions in 2 countries.

Morteza ShamsZoonotic Diseases Research Center Ilam University of Medical Sciences Ilam Iran.
Ayoub RashidiZoonotic Diseases Research Center Ilam University of Medical Sciences Ilam Iran.
Jasem MohamadiZoonotic Diseases Research Center Ilam University of Medical Sciences Ilam Iran.
Mohamad MoradiZoonotic Diseases Research Center Ilam University of Medical Sciences Ilam Iran.
Reza PakzadZoonotic Diseases Research Center Ilam University of Medical Sciences Ilam Iran.
Razi NaserifarZoonotic Diseases Research Center Ilam University of Medical Sciences Ilam Iran.ORCID 0000-0001-6946-9083
Jahangir AbdiZoonotic Diseases Research Center Ilam University of Medical Sciences Ilam Iran.
Fariba GhelichiZoonotic Diseases Research Center Ilam University of Medical Sciences Ilam Iran.
Arezoo BozorgomidInfectious Diseases Research Center, Health Institute Kermanshah University of Medical Sciences Kermanshah Iran.
Nahid MaspiZoonotic Diseases Research Center Ilam University of Medical Sciences Ilam Iran.
Azra KenarkoohiDepartment of Microbiology, Faculty of Medicine Ilam University of Medical Sciences Ilam Iran.ORCID 0000-0003-4077-9824
Yasin MohammadiMedicine Faculty Kateb University Kabul Afghanistan.
Amir AbdoliZoonoses Research Center Jahrom University of Medical Sciences Jahrom Iran.ORCID 0000-0003-4326-4586
Shahab FalahiZoonotic Diseases Research Center Ilam University of Medical Sciences Ilam Iran.ORCID 0000-0002-3764-2168
Medical University of Ilam · IRImam Khomeini Hospital · IRJahrom University · IRKabul University · AFKermanshah University of Medical Sciences · IR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background and Aims: Cutaneous leishmaniasis (CL) is a severe parasitic disease affecting people, mostly in underdeveloped nations. As a zoonotic infection yearly incidence of CL depends on several parameters such as demographic, epidemiological, and environmental factors as well as prevention and control measures. The sudden outbreak of pandemics such as SARS-Corona-Virus-2 pandemic, can probably affect the incidence or reporting of other diseases, especially infectious diseases, in various ways such as pressure on health systems, providing sanitary services and its components, lockdowns and changes in people's living habits. Aim: This study aimed to evaluate the COVID-19 impact on the incidence and other epidemiological aspects as well as control measures of CL in Ilam Province-Iran. Methods: Required data was extracted from the CL registration system in Ilam from 2014 to 2021 to demonstrate the trend of CL incidence before and after COVID-19 pandemic. Results: Based on our results, a declining pattern of CL incidence was observed, accompanied by the advent and intensification of the viral pandemic in Iran and Ilam province. Although, this decreasing pattern was not integral in all areas, and even increase in CL detection was emphasized in some regions. Conclusion: It may be inferred that the COVID-19 pandemic may disrupt treatment programs of CL cases, rodent nest destruction, and fighting vector insects.

Indexed as

case findingCOVID‐19cutaneous leishmaniasisepidemiologyhighimpactpandemic

Identifiers

PMID37599657
PMCPMC10432587
OpenAlexW4386013131

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.